© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Scientific history rarely marches in a straight line, and 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol reminds me just how winding the trail can get in organic chemistry. Back in the day, pyridine derivatives drew attention for their roles in everything from vitamins to weird enzymatic pathways. The furo[3,4-c]pyridine skeleton, with its fusion of an aromatic ring and an oxygen-containing five-membered ring, made itself known to researchers digging deep into heterocyclic chemistry. Over time, substitutions at the 6-position became the subject of investigations into new activities and reactions. The addition of a methyl group at this point gave a compound that kept chemists busy with new questions and reactions, especially when coupled with a hydroxy group at position 7, which introduced possibilities for hydrogen bonding, solubility tuning, and biological mimicry.
6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol isn’t flashy, but it gets attention where it counts. That methyl group gives the molecule bulk and changes its electronic character, making it less prone to certain nucleophilic attacks while opening new doors for functionalization. The pendant hydroxy group adds a polar handle, shifting the solubility landscape and letting the molecule interact in unique ways with enzymes, receptors, or even catalysts. These subtle changes make a big difference; I’ve seen researchers shift focus from flat, simple rings to compounds like this, because the tweaks can mean the difference between a dead end and a viable new lead in drug development or material science.
This compound has a solid backbone with some interesting quirks. The fused ring system brings a measure of rigidity, which changes how it fits into larger molecular assemblies. In lab hands, this one typically presents as a pale powder, sometimes with a hint of yellow or off-white, showing it’s not one to grab attention by look alone. Melting points tend to cluster in a moderate range, thanks to that fused ring and the presence of polar functional groups. The methyl group at position 6 and the hydroxy group at position 7 both nudge the molecule’s polarity in opposed directions, so solubility testing often means a bit of trial and error. You learn quickly that a few tweaks on this backbone swing the solubility from organic solvents to water or vice versa, which matters deeply if you’re loading it in a reactor or trying to bio-test it in living systems.
Regulating chemical identity stands as a necessary buffer to confusion. Labels for this compound usually call out the full IUPAC name (even if most folks prefer shorthand) and record purity, since minor contaminants can flip the properties instantly. Molecular weight, batch number, and storage conditions also get their place on the label. Incorrect storage—exposing to moisture or light—tends to effect small but impactful degradation, something any bench chemist has seen after finding an old bottle where the content shifted color or developed a faint odor. Accurate labeling and clear storage instructions matter far more with these heterocycles than with old standbys like benzene or toluene, as a single site of oxidation can wreck your workup or even risk an unknown hazard.
Synthesizing 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol usually means stitching together two key pieces: a suitable pyridine precursor and a way to close the furan ring. Chemists often begin with a substituted pyridone, then rely on cyclization using mild acid or base after methylation at the right carbon. Some approaches run through a Paal-Knorr variant, while others lean on oxidative cyclization of enaminones. The challenge always comes down to selectivity—one wrong move can yield ring-opened products or undesired tautomers. After isolation, purification goes a step further with careful chromatography, often on silica gel, since the compound’s polarity puts it right in the sweet spot for messy overlapping elution. Yields are rarely perfect, but experience helps get you most of the way there.
This skeleton sits at a crossroads where multiple modifications can pull it in strikingly different directions. That hydroxy group can get shifted into a chloro or alkoxy group for introducing bulk or changing reactivity. The methyl at position 6 blocks unwanted electrophilic substitutions but invites oxidation or functionalization to bulkier side chains, useful for tuning target binding properties in pharmaceutical leads. Diels-Alder and Michael-type additions rarely succeed right on the ring due to crowding, but nucleophilic aromatic substitutions sometimes slip through, letting creative chemists wedge in fluorine or triflates. The compound serves as a starting point for fluorescent probes, enzyme inhibitors, or polymer additives.
Organic chemists have a long tradition of giving mouthfuls of names to new compounds. 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol has gone by shorter tags—sometimes you’ll see “6-methylfuropyridinol” or “methyl-furopyridinol” pop up in publications. In the lab, people might just call it “that methyl hydroxy furopyridine.” Differences in naming can make data searches frustrating; it’s easy to miss a promising study because someone used a synonym you didn’t expect. This inconsistency shows the need for universal chemical identifiers like InChI or CAS numbers, which help bring consistency and prevent duplicating others’ mistakes or reinventing the wheel with already-known chemicals.
Heterocycles deserve respect. Even with low-to-moderate toxicity, accidental exposure in the lab has led to eye irritation, brief headaches, or even mild respiratory effects. Good ventilation and gloves rate as essential, but too many researchers have short-circuited safety steps during a late-night workup. Proper containment and waste disposal saves everyone headaches later; heterocyclic rings can persist in the environment and sometimes cause bigger issues later down the line. Material safety data brings home the risks, but seeing how these compounds interact with living cells in a petri dish gives a much sharper warning—subtle neuroactive effects at moderate concentrations warrant real caution, and nobody wants to be the case study for an accidental overdose. Training new chemists to respect these compounds, with sample drills and clear safety notes, keeps accidents rare.
Over the years, this compound and its relatives have crept from academic curiosities into real-world applications. Medicinal chemistry circles tune these cores to bind kinases, G-protein coupled receptors, or as parts of antimicrobial scaffolds. The hydroxy group often enables hydrogen bonding in enzyme binding pockets or solubility modulation, which can mimic key metabolites. Material science teams look at the unique fused rings for photochemical stability, given that the oxygen and nitrogen in the backbone nudge excited state properties—these could inspire new sensors, dyes, or semiconducting materials. Agrochemical researchers show interest too, trying to bypass pest resistance by tweaking ring electronics, leveraging a methyl group’s subtle effect on metabolism. It’s remarkable to watch a molecule shift gears from one end of industry to the other, each time filling a niche that wasn’t obvious when it first hit the glassware.
In today’s research, the focus is not simply on making this molecule, but finding meaningful uses for it. Teams screen new analogs in bioactivity panels, track binding affinities to disease targets, or search for photostability in harsh conditions. I’ve known postdocs who discover a subtle tweak—switching the methyl to an ethyl, or shifting the hydroxy up a carbon—that suddenly unlocks activity against antibiotic-resistant strains or opens new reactivity in polymerization. Reliable access to high-purity compound, coupled with robust analytical data, helps keep development efforts aligned with real-world risks and opportunities. Intellectual property constantly nips at progress, as teams race to publish findings and patent modifications before rivals do. Collaboration between pharma, material science, and academic teams gives this molecule much more exposure than a standard benzoic acid derivative ever gets.
Testing brings the reality of toxicity into clear focus. Early screening shows the molecule isn’t acutely toxic to mammalian cell lines, but chronic exposure data is hard to collect and interpret. The hydroxy group affects metabolism by making it more prone to glucuronidation, but related ring systems sometimes interfere with the nervous system. Animal studies done with larger doses sometimes turn up mild liver enzyme elevation, but not the organ devastation seen in older pyridinic drugs. Researchers echo a cautious optimism: here lies a scaffold with real promise, but every new derivative earns a careful eye before clinical or consumer exposure. Data on aquatic toxicity remains sparse—a problem as research labs flush more complex molecules down the drain each year. Getting ahead of this means funding better environmental toxicity studies now, not later.
It’s easy to see how much room there is for growth. New computational models highlight the molecule’s fit in unexplored targets. Better synthetic strategies could streamline access to analogs currently out of reach. Real progress in the future will come by linking academic curiosity with industrial pragmatism, using this core not only as a drug scaffold but as an entry into better-performing polymers, smarter dyes, or greener agrochemicals. Emphasizing transparent toxicity research and safer lab techniques could ensure the molecule’s promise doesn’t backfire down the road. Seeing this compound go from a structural footnote to a substance with serious possibilities gives hope for those willing to do the hard work, follow the data, and remember that small tweaks can unlock major advances when combined with real-world scientific sense.
6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol might fly under the radar outside specialist labs, but its practical impact speaks loudest among chemical researchers and medicinal chemists. For the people in white coats looking for new breakthroughs, molecules like this one are not just a curiosity—they’re real tools that bring new molecules to life. Years ago, my work relied heavily on structures with similar fused rings and heterocycles. These often served as building blocks to design new compounds, leading to drug candidates with potential to solve medical problems that older medicines failed to address.
This compound’s fused ring structure appeals to the imagination of medicinal chemists. Researchers turn to it while seeking new treatments for everything from neurodegenerative diseases to bacterial infections. You don’t get blockbuster drugs without running hundreds, sometimes thousands of variations. Heterocycles like this one help create skeletons, core structures that become new hopefuls in the big drug hunt. Studies show that heterocycles remain present in more than half of new drugs approved every year. That suggests strong demand for these versatile core structures. Introducing a methyl group at the right spot often brings subtle changes in a molecule’s behavior—the way it attaches to proteins, dissolves in bodily fluids, or avoids being broken down too fast by liver enzymes.
Many biotech startups and university labs keep 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol in their compound libraries. These libraries keep the pipeline alive in drug discovery. Screening tests can sift through compounds by the thousands, looking for those few that switch off a rogue gene or block a dangerous enzyme. This single molecule often becomes a seed for dozens of analogs—each one a little different, hoping to improve some property, reduce a side-effect, or last longer in the body.
Not all roads lead to the pharmacy. Chemists often use complex small molecules as intermediates to make specialty chemicals, catalysts, or dyes. The backbone of 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol promises reactivity, giving synthetic chemists options to add functional groups, expand rings, or introduce chiral centers. These modifications come up in the design of sensors, organic electronics, or research tools used to probe unknown biology. Some researchers explore such compounds as ligands in metal complexes or in the search for new agricultural chemicals.
Those outside the lab might not hear much about this molecule, but patent databases and research journals tell another story. A search through chemical patent reports reveals steady entries over the recent years featuring this scaffold in potential drug candidates or advanced chemical processes. Journal articles discuss structure-activity relationships after shifting just a single atom or group around its rings, chasing after noticeable differences in lab tests. Excitement in the field rarely comes from the flashiest new technology. Sometimes, it arrives quietly, through incremental improvements in old molecules or structures like this one, quietly nudging science forward.
Innovation also demands attention to challenges like sustainable sourcing and responsible lab practices. Researchers now look for ways to produce complex molecules with less waste and safer solvents. Making compounds like 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol efficiently—without noxious byproducts—has become a high priority for both the environment and worker safety. Green chemistry methods win funding and kudos for labs that manage to blend creative exploration with responsible stewardship.
The future promises new surprises with every tweak and test. Someone might discover a new pathway to treat stubborn diseases, or maybe invent safer crops, all thanks to structures that began as small, imaginative synthetic targets in the lab. That’s where this compound finds its real importance—as a test case, a building block, a path to something bigger.
Scientists learn a lot about a compound from its name, even before seeing a structure. Here, "6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol" says a lot. The backbone is a fused ring system, blending a furan and a pyridine, both widely studied for their reactivity. To picture this, imagine a six-membered pyridine ring with a furan ring attached at just the right points. A methyl group sits at position 6, and a hydroxyl group attaches at position 7.
Drawing such a molecule on paper, chemists notice how tweaks—like adding the methyl or hydroxyl—play with the molecule's electron density, physical properties, and how it might react or interact with enzymes. With these small choices, nature and scientists alike direct compounds to potential jobs as flavoring agents, drug candidates, or lab reagents. These chemical tricks shape what a compound can do.
Tiny changes to a structure swing a molecule from bland to biologically active. In this one, the fused rings create rigid angles, which tend to set a molecule's three-dimensional shape in stone. That means the way it fits into biological machinery changes, possibly offering unique effects—or unexpected side effects.
The methyl group at position 6 tinkers with solubility, electronic character, and how the ring feels to other molecules. Say the methyl boosts lipophilicity: that can affect how this molecule gets through cell membranes, or even its shelf life. Meanwhile, the hydroxyl at position 7 opens conversations for hydrogen bonding, which might lead the compound to stick around in different parts of the body, or bind tightly to particular proteins. In medicinal chemistry labs, features like these make or break a candidate.
Labs look at fused heterocycles like this when hunting for new therapies. Furan and pyridine rings pop up in many drugs, antibiotics, and vitamins. This structural class carries the baggage of history: some similar compounds treat diseases, others never pass safety screens thanks to toxicity. Groups like methyl and hydroxyl modulate these risks, alongside benefits.
Reliable information on the chemical structure and properties helps set a foundation for safe handling, measurement, and risk assessment. The research world takes these molecules seriously because subtle changes create major surprises, both good and bad. So, sharing verified structures and data supports trust in research outcomes.
Looking at challenges, open access to clear, accurate depictions—both 2D sketches and 3D models—should be routine. Confusion arises if names get tangled, or if mistakes slip into databases. I’ve seen mishaps when a researcher trusted a poor-quality synthesis report or a database entry missing stereochemistry. It takes a team effort: chemists validate, journals demand structural proof, databases vet information, and educators teach future scientists to scrutinize every line and hydrogen on a drawing.
Digital chemistry tools now let anyone pull up a structure or shaker up a model. Yet the human eye catches things that algorithms miss. When teaching students about furo-pyridines or similar rings, I encourage actually drawing, imagining, and checking each atom. Building trust in data takes attention to detail—people, not databases alone, keep research honest.
Lab work always brings the challenge of managing chemicals that aren’t in every textbook. Looking at 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol, a synthetic compound not common in large-scale handling, the question of safety isn’t just academic. Few have used it outside a research context, and that often means reaching for the MSDS just to figure out where to start. Always check for the latest data, but don’t expect a complete safety rundown on such niche compounds.
Similar heterocyclic compounds can pose risks ranging from skin irritation to longer-term health effects. Organic molecules with related structures sometimes cause issues like respiratory irritation or sensitization if inhaled or allowed onto unprotected skin. The story is not always the same, but caution gains you far more than bravado in unknown territory.
It’s smart to take the “treat every unknown as hazardous” approach. Years spent in synthetic chemistry taught me that surprises often come from the least familiar bottles. Even low-toxicity chemicals can turn problematic in closed or poorly ventilated spaces. Volatile compounds escape easily and enter the air, putting everyone nearby at risk of headaches or worse.
Handling aromatic and heterocyclic chemicals often means managing both the powder and any vapors. It’s not just the obvious pouring or mixing that releases material—you’d be amazed at what can escape during a quick weighing or cleanup.
Basic lab safety matters, no matter the workload. Nitrile gloves, safety goggles, and a lab coat should stay on from the moment the bottle opens. Fume hoods are not just for show. Even if you think a compound isn’t particularly volatile, using a hood keeps the air clean. Experience shows the difference between believing nothing will happen and having a safety net for the rare day when it does.
Key here is to avoid creating dust or aerosols. Many underestimate how easily powders can become airborne. Keep all weighing, transferring, or dissolving inside the hood. Wet methods—dissolving into a solvent before transferring—further cut down the airborne dust risk. After handling, wash hands thoroughly even when gloves seemed intact.
Many organic compounds degrade in sunlight or over time, sometimes creating more hazardous breakdown products. Use amber glass or opaque bottles and keep the storage cool and dry. Label everything, even short-term samples, with date and hazards.
Chemical waste collection often turns into a gray area for novel organics. Always check with waste coordinators about acceptable disposal routes. Never tip leftovers down the drain, even very dilute solutions. Years in shared labs have shown me how fast unknown waste can create safety issues when protocols aren’t followed.
Every lab benefits from a culture that values asking questions over sprinting ahead. If there’s no specific safety data, ask for advice from a safety officer or a chemist familiar with similar structures. Keep incident logs up to date; even minor exposures help build a knowledge base for future researchers. Safety builds trust, making it easier for new people to step in and work with confidence.
With lesser-known chemicals like 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol, real safety comes from a thoughtful approach and clear habits, rather than waiting for something to go wrong.
Understanding the molecular weight of a compound like 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol often feels like basic arithmetic until you’re elbow-deep in an experiment that hinges on precision. The actual value, calculated from its molecular formula (C8H9NO2), comes out to 151.16 g/mol. This isn’t a number to gloss over, especially in labs pushing for reproducibility and tight controls. Every mole delivered weighs in at 151.16 grams. That figure sets the baseline for everything from reagent calculations to purity checks and shipping quotes.
Years ago in undergraduate organic chemistry labs, measuring out compounds based on their molecular weights felt tedious. Yet the whole workflow—yields, stoichiometry, downstream reactions—depends on accuracy at this level. Missing the target by a fraction of a gram leads to wasted time and unreliable results, especially as you start thinking about scaling up or troubleshooting odd results. It’s easy to overlook how little room there is for error in analytical labs, and how a fundamental miscalculation sends problems rippling through everything that follows.
Digging into the bigger picture, pharmaceutical research doesn’t just stop at identifying a compound or predicting activity. The molecular weight influences solubility, absorption, and even regulatory considerations. Compounds over 500 g/mol tend to get flagged for poor bioavailability, but lighter molecules, like this pyridinyl derivative at 151.16, often move through development pipelines more smoothly. A sound grasp of these principles can make the difference between an idea hitting the market or getting dropped early on.
There’s no shortcut for this work. Drug designers, analytical chemists, and process engineers all reference this figure as a constant. Accurate analytical balances come out, calibration standards get checked twice, and research progress follows the data downstream. Formula weights connect with safety protocols, environmental handling, and compliance paperwork as well. Having that number at hand keeps surprises to a minimum.
In a world overflowing with digital calculators and chemical inventory software, it’s easy to forget that chemists lean on hard-won experience to spot errors before they grow into problems. I’ve watched seasoned labmates catch mistakes in real time—they know something’s off if a few tenths of a gram don’t line up. Checking each molecular weight used to feel redundant; now, with quality systems and audits in place, it provides peace of mind for the entire team.
Textbook facts only get you so far. Reliable research depends on getting these numbers right, time after time. In pharmaceutical development, regulatory filings specify the exact formula and associated weights to prevent confusion or mislabeling. Shipping departments need those numbers to comply with customs. Even in academic settings, the right foundation leads to credible publications and new discoveries.
Most references confirm 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol at 151.16 grams per mole, matching the calculated sum of its atomic components: carbon (12.01 x 8), hydrogen (1.008 x 9), nitrogen (14.01), and oxygen (16.00 x 2). Trust follows transparency, especially with data that professionals double-check by hand along with software. Reliable, up-to-date sources matter because no one wants a mistake immortalized in a published paper or regulatory application.
A commitment to accuracy, routine cross-checks, and respect for the numbers forms the backbone of reliable chemical research. Keeping standards high pays off in confidence, results, and professional pride—qualities that don’t fade as tools grow more advanced.
Scroll through the pages of chemical catalogs, and 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol doesn’t spark the kind of recognition you get with aspirin or ibuprofen. It crops up as another mouthful in the thick forest of new synthetic compounds making their entrance into labs around the world. To date, there’s no wave of patents or clinical trials declaring this molecule the next blockbuster drug. Folks working in pharmaceutical research might notice it more as a structural curiosity than a household name.
Some of the best ideas in medicine start in the quiet corners of chemical libraries. With its fused-ring structure, this compound draws attention from medicinal chemists who love to experiment with heterocycles in early-stage screening. The pyridine ring shows up in several successful drugs, and often, tiny tweaks on the scaffold uncover new activity. Published work on this exact structure remains thin—no splashy feature in the big-name pharmaceutical journals. Still, researchers know well the value of unexplored chemical space, and journals track a steady hum of interest in similar compounds for their biochemical versatility.
Picking through databases, it’s easy to spot hits where related furopyridines show antimicrobial or neuroactive effects. These results give hope, but as of now, no evidence links this specific compound to a proven medical application. Academic teams have gone as far as running it through some assays and collecting toxicity data, but nothing strong enough that pharmaceutical companies are putting it on a development pipeline. In terms of pure data, this molecule currently lives in the “potential” category, not in the “proven” folder.
My own time in the lab taught me patience. The earliest days of drug discovery rarely get recognition. Novel scaffolds like this may not solve any clinical puzzles immediately, but every new skeleton expands the set of tools drug designers wield when targets get harder and resistance grows. Scientists have learned from old mistakes; sometimes the compound that flops in one project comes back strong after a bit of tweaking. Chemistry keeps surprising us, and the “nothing found yet” label doesn’t close the story. It just marks the start line for folks willing to look under the hood.
For this compound, practical movement would mean more team-ups between academic groups and industry. Screening programs could include this scaffold in libraries, seeing how it behaves against emerging antimalarial or antiviral targets. A better look at solubility, stability, and metabolic profile would round out the picture for any future clinical hopes. Meanwhile, new computational models could predict activities before someone commits precious resources to long cycles of synthesis and testing. Open data sharing would speed things up, letting researchers drop dead ends quickly and pour effort into more promising analogues.
Most people outside scientific circles won’t hear much about obscure compounds until one of them changes the face of a disease. Yet, importance hides in these quiet stages—growing the chemical toolbox to match today’s health challenges. The next time you read about a headline drug, remember that its path probably started with an overlooked structure, a hunch based on experience, and countless hours of trial in labs around the world. In that spirit, 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol deserves a spot in the ongoing story of medical research, patiently waiting its turn on the main stage.
| Names | |
| Preferred IUPAC name | 6-methyl-2H-furo[3,4-c]pyridin-7-ol |
| Other names |
6-Methyl-7-hydroxy-1,3-dihydro-2H-furo[3,4-c]pyridine 6-Methyl-7-hydroxy-1,3-dihydrofuro[3,4-c]pyridine 7-Hydroxy-6-methyl-1,3-dihydrofuro[3,4-c]pyridine |
| Pronunciation | /ˈsɪks ˈmɛθɪl waɪˈæn θri daɪˈhaɪdrəˌfjʊəroʊ θri faɪv si paɪˈrɪdɪn ˈsɛvən oʊl/ |
| Identifiers | |
| CAS Number | 1186198-70-6 |
| 3D model (JSmol) | `/showmol/pdb/6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol` |
| Beilstein Reference | 77009 |
| ChEBI | CHEBI:142350 |
| ChEMBL | CHEMBL2121443 |
| ChemSpider | 30714694 |
| DrugBank | DB08399 |
| ECHA InfoCard | 12d8b2d4-1c3a-4bfd-88f6-60735c983b8a |
| Gmelin Reference | 140727 |
| KEGG | C21037 |
| MeSH | C570892 |
| PubChem CID | 155799330 |
| RTECS number | SY8577000 |
| UNII | VC4I7G4K1Y |
| UN number | Not assigned |
| CompTox Dashboard (EPA) | 6TT6JJ967F |
| Properties | |
| Chemical formula | C8H9NO2 |
| Molar mass | 139.15 g/mol |
| Appearance | Light yellow solid |
| Odor | Odorless |
| Density | 1.35 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 0.18 |
| Acidity (pKa) | 12.8 |
| Basicity (pKb) | 6.37 |
| Magnetic susceptibility (χ) | -51.92·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.613 |
| Dipole moment | 2.33 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 318.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | −216.1 kJ·mol⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -3603 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | N07XX09 |
| Hazards | |
| Main hazards | Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302+H312+H332 Harmful if swallowed, in contact with skin or if inhaled. |
| Precautionary statements | P261, P280, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | 1-2-0 |
| Flash point | Flash point: >110 °C |
| NIOSH | Not Listed |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol is not established. |
| REL (Recommended) | 30 mg/m³ |
| IDLH (Immediate danger) | Not Listed |
| Related compounds | |
| Related compounds |
1,3-Dihydrofuro[3,4-c]pyridin-7-ol 6-Methyl-1,3-dihydro-2H-furo[3,4-c]pyridin-7-one 6-Methylpyridin-3-ol 7-Hydroxyfuro[3,4-c]pyridine 5-Methyl-2-pyridone |
